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Abstract
 
We analyzed the interaction between human peripheral blood natural killer (NK) cells and
monocyte-derived immature dendritic cells (DC). Fresh NK cells were activated, as indicated
by the induced expression of the CD69 antigen, and their cytolytic activity was strongly aug-
mented by contact with lipopolysaccharide (LPS)-treated mature DC, or with immature DC in
 
the presence of the maturation stimuli LPS, 
 
Mycobacterium tuberculosis
 
 or interferon (IFN)-
 
 
 
.
Reciprocally, fresh NK cells cultured with immature DC in the presence of the maturation
stimuli strongly enhanced DC maturation and interleukin (IL)-12 production. IL-2–activated
NK cells directly induced maturation of DC and enhanced their ability to stimulate allogeneic
 
naive CD4
 
 
 
 T cells. The effects of NK cells were cell contact dependent, although the secre-
tion of IFN-
 
 
 
 and TNF also contributed to DC maturation. Within peripheral blood lympho-
cytes the reciprocal activating interaction with DC was restricted to NK cells, because the other
lymphocyte subsets were neither induced to express CD69, nor induced to mature in contact
with DC. These data demonstrated for the first time a bidirectional cross talk between NK cells
and DC, in which NK cells activated by IL-2 or by mature DC induce DC maturation.
Key words: dendritic cell maturation • cytotoxicity • natural killer cells • cytokines • human
 
Introduction
 
NK cells are effector cells of innate resistance that are able
to lyse a variety of cells, including tumor and virus-infected
cells, spontaneously in the absence of Ag-specific recogni-
tion and clonal expansion (1). The cytolytic activity of NK
cells is augmented by IL-2 and, to a lesser extent, by other
cytokines, including IL-12 and IFN-
 
 
 
. Activated NK also
acquire the capacity to lyse target cells that are resistant to
 
resting NK cells, and produce cytokines, particularly IFN-
 
 
 
.
IFN-
 
 
 
–producing NK cells regulate innate resistance by
activating phagocytic cells and priming APC for IL-12 pro-
duction, thus shaping adaptive immunity toward a Th-1
response (2).
Dendritic cells (DC)
 
*
 
 augment the cytotoxic functions of
NK cells (3–5). DC are APC with the unique ability to in-
duce primary immune responses. Resting immature DC
reside in all tissues. Signals inducing maturation of DC in-
clude microbial products and interaction with activated T
lymphocytes, which signal through binding of their Ag re-
ceptor to peptide–MHC class II complexes, and through
costimulatory molecules. Mature DC accumulate long last-
ing, MHC–peptide complexes on their surface, upregulate
costimulatory molecules, secrete cytokines, and migrate to
secondary lymphoid tissues where they trigger specific T
cell responses (6).
In this study, we analyzed the interaction between human
peripheral blood NK cells and monocyte-derived DC upon
the activation/maturation of either cell type, and found a
potent, activating cross talk between NK cells and DC.
 
Materials and Methods
 
Cells and Cell Culture. 
 
All reagents used in this study were
tested for low endotoxin contamination using the Limulus amoe-
bocyte assay (Associates of Cape Cod). PBMC were from healthy
 
human donors and PBL were from PBMC after monocyte deple-
tion by plastic adherence. DC were obtained by 6-d culture of plas-
 
tic-adherent PBMC in medium with 12 ng/ml IL-4 (10
 
8
 
 U/mg;
CLB) and 50 ng/ml GM-CSF (1.10
 
7
 
 U/mg; Novartis). For NK
cell purification, frozen aliquots of PBMC were thawed and de-
pleted of T and B lymphocytes and monocytes by magnetic de-
pletion using FITC–anti-CD3, –anti-CD19, and –anti-CD14
mAb, goat anti-FITC–magnetic microbeads, BS separation col-
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umns, and a VarioMACS magnet (Miltenyi Biotec). After deple-
tion, FITC-stained cells were less than 1%, and CD16
 
 
 
/CD56
 
 
 
NK cells were from 85 to 95%. NK cells were depleted by mag-
netic depletion using FITC–anti-CD16 and –anti-CD56 mAb.
NK cells (0.25 
 
 
 
 10
 
6
 
/well) and DC (0.1 
 
  
 
10
 
6
 
/well) were cul-
tured together or separately in 48-well plates for 18 h in or out of
the presence of the following stimuli: LPS (1 
 
 
 
g/ml; Sigma-
Aldrich); heat-killed 
 
Mycobacterium tuberculosis
 
 cell suspension
(H37Rv strain, 1.5 
 
 
 
 10
 
6
 
 CFU/ml; provided by L. Fattorini, Is-
tituto Superiore di Sanità, Rome, Italy); IFN-
 
 
 
, (1,000 U/ml;
Schering-Plough Laboratory for Immunological Research); IL-2
(400 U/ml; provided by Chiron Corp.). Where indicated, imma-
ture DC were incubated for 18 h in the presence or the absence
of LPS or IFN-
 
 
 
, and washed before coculture with resting NK
cells for an additional 18 h. IL-2–activated or untreated NK cells,
PBL, and NK-depleted PBL were obtained by 18-h (NK) or
48-h (PBL and NK-depleted PBL) treatment with or without
IL-2 (250 U/ml), and washed before culture for an additional 18 h
with immature DC. The following neutralizing mAb: B133.3,
anti–IFN-
 
 
 
 and B154.2, anti-TNF, were used as ascites, 1:200.
 
Cell-mediated Cytotoxicity Assay. 
 
NK cells and DC, cultured
alone or together, were washed and incubated at different effec-
tor–target ratios in U-bottomed microtiter plates, with 5 
 
 
 
 10
 
3
51
 
Cr-labeled Daudi cells for 4 h.
 
Immunofluorescence Assay. 
 
Expression of the antigens CD86,
CD83, CD80, HLA-DR, and CCR7 was detected on DC by di-
rect (PE-conjugated anti-CD86 and anti-CD80, FITC-conjugated
anti-CD83, and D1-12 mabs), or indirect (anti-CCR7 mAb)
immunofluorescence and flow cytometry (Epics XL; Beckman
Coulter). CD69 antigen expression was detected on PBL by dou-
ble staining with PE-Cy5–conjugated anti-CD69 (Immunotech)
mAb and FITC-conjugated anti-CD3, or anti-CD16 plus anti-CD56
mAbs. In DC–NK cell cocultures, viable DC were distinguished
from NK cells or dead DC by side and forward scatter parameters.
Percent DC recovery was calculated as the number of viable DC
after culture with NK cells, relative to DC cultured alone.
 
Detection of IFN-
 
 
 
 and IL-12 p70 and p40. 
 
These cytokines
were quantitated in cell culture supernatants by RIA using the
following mAb: B133.1 and B133.5 for IFN-
 
 
 
; 12H4 and C8.6
for IL-12 p70; and C11.79 and C8.6 for IL-12 p40. Recombi-
nant human IFN-
 
 
 
 (specific activity 2 
 
 
 
 10
 
7
 
 U/mg; provided
by Roussel Uclaf), IL-12 p70, and p40 were used as reference
standards.
 
Naive CD4
 
 
 
 T Lymphocyte Proliferation. 
 
DC were cultured
for 18 h with medium, LPS, or with IL-2–activated or untreated
NK. NK cells were removed from DC by magnetic depletion.
After irradiation (3,000 rads), DC were cultured at graded num-
bers with allogeneic PBL (0.8 
 
 
 
 10
 
5
 
 cells/well) that had been de-
pleted of CD45RO
 
 
 
, CD8
 
 
 
, CD16
 
  
 
and, CD56
 
 
 
 by mAbs and
goat anti–mouse IgG conjugated magnetic beads. Proliferation
was evaluated after 5-d culture by 
 
3
 
H-TdR uptake.
 
Results
 
Activation and Enhancement of Cytotoxic Activity in NK
Cells Cultured with DC in the Presence of Different Stimuli.
 
NK cells after an 18-h culture in the presence or absence of
DC, mediated minimal cytotoxicity against the NK-resis-
tant Daudi cell line (Fig.1 A). In the absence of DC, heat-
killed 
 
M. tuberculosis
 
, and IFN-
 
 
 
, but not LPS, modestly
enhanced NK cell–mediated cytotoxicity (Fig. 1 A). How-
ever, NK cell cytotoxicity was highly augmented after an
18-h culture with autologous (Fig. 1 A) or allogeneic (un-
published data) DC in the presence of 
 
M. tuberculosis
 
, IFN-
 
 
 
,
or LPS. Identical results were obtained with two other
tumor target cell lines (unpublished data). LPS-pretreated
DC, but not IFN-
 
 
 
–pretreated DC, induced strong cyto-
toxic activity in cocultured NK cells (Fig. 1 B). When PBL
were cultured with LPS-pretreated DC, CD69 activation
antigen was induced in most NK cells (CD16
 
 
 
, CD56
 
 
 
)
Figure 1. Activation and gen-
eration of cytotoxic activity in
NK cells cultured with DC. (A)
Purified NK cells and DC were
cultured for 18 h separately or to-
gether in medium, or in the
presence of killed M. tuberculosis
(M. t.), IFN- , LPS, IL-2, or la-
tex particles. (B) DC were cul-
tured for 18 h in medium, or with
LPS or IFN- , and washed before
18-h coculture with fresh NK
cells. Cytolytic activity (A and B)
was evaluated against the Daudi
cell line. (C) DC were cultured
for 18 h in medium or with LPS
and washed before a 18-h cocul-
ture with PBL; CD69 expression
was evaluated on CD56 ,
CD16 , or on CD3  PBL by
double immunofluorescence. 
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but not in T cells (Fig. 1 C). Separation of NK cells and
DC by a porous membrane during the culture in the pres-
ence of LPS completely abrogated the induction of cyto-
toxic activity, whereas neutralizing anti–IL-12 or anti–IL-2
mAb did not prevent activation of NK cell cytotoxicity, or
CD69 expression (unpublished data).
 
Cytokine Production and DC Activation in Cultures of NK
Cells and DC. 
 
The production of IL-12 heterodimer
(p70), IL-12 free heavy chain (p40), and IFN-
 
 
 
 was ana-
lyzed in cultures of NK cells and/or DC (Fig. 2 A). DC
produced IL-12 p70 after stimulation with LPS, but not
with 
 
M. tuberculosis
 
 or IFN-
 
 
 
. The presence of NK cells in
culture with DC significantly increased IL-12 p70 produc-
tion after stimulation with LPS, but not with 
 
M. tuberculosis
 
and IFN-
 
 
 
. DC stimulated with either LPS or 
 
M. tuberculo-
sis
 
 produced considerable amounts of the free p40 chain,
and the presence of NK cells increased its production.
IFN-
 
 
 
 was observed in supernatants of LPS-, and to a lesser
extent, 
 
M. tuberculosis
 
–treated NK–DC cocultures, whereas
it was almost undetectable in supernatants of NK cells or
 
DC cultured alone, irrespective of the stimulus (Fig. 2 A).
A neutralizing anti–IL-12 mAb almost completely abro-
gated IFN-
 
 
 
 production (unpublished data). In IFN-
 
 
 
–
treated NK–DC cocultures, IFN-
 
 
 
 was undetectable.
LPS induced strong upregulation of CD86 antigen on
DC (Fig. 2 B). 
 
M. tuberculosis
 
 and IFN-
 
 
 
 induced lower lev-
els of CD86 antigen than LPS, whereas IL-2 and latex beads
had no effect (unpublished data). In the absence of matura-
tion stimuli, the addition of fresh NK cells to DC cultures
had little or no effect, but in the presence of IFN-
 
 
 
, 
 
M.
 
 
 
tu-
berculosis
 
, or LPS, NK cells strongly enhanced CD86 expres-
sion (Fig. 2 B). The NK cell enhancement of LPS-induced
CD86 expression was more evident when suboptimal con-
centrations of LPS were used (unpublished data).
 
IL-2–activated NK Cells Induce the Functional Maturation of
DC. 
 
The enhanced expression of CD86 and IL-12 in
NK–DC mixed cultures, in conditions in which both NK
cells and DC are activated, suggests that not only do mature
DC activate NK cells, but also that activated NK cells in-
duce maturation of DC. To dissociate the two phenomena,
NK cells were preactivated with IL-2. Immature DC cul-
tured for 18 h with IL-2–activated NK cells, but not with
untreated NK cells, strongly expressed several maturation
markers (Fig. 3 A). After elimination of NK cells, these DC
induced proliferation of allogeneic naive CD4
 
 
 
 T cells
(Fig. 3 B), at levels comparable to those induced by LPS-
treated mature DC.
The number of DC recovered at the end of the 18-h
culture with IL-2–activated NK cells (62
 
   
 
13% average
recovery 
 
 
 
 SD, 
 
n 
 
  
 
10) was lower than after coculture
with untreated NK cells (92
 
   
 
13), suggesting that the DC
maturation induced by IL-2–activated NK cells is accom-
panied by the lysis of a variable proportion of DC.
PBL treated for 48 h with IL-2 also induced CD86 ex-
pression on DC (Fig. 3 C). However, depletion of NK
cells from IL-2–activated PBL completely abolished this ef-
fect, demonstrating that among PBL, only NK cells are ac-
tivated by IL-2 to induce DC maturation.
 
Both Cell to Cell Interaction and Cytokines are Responsible for
the Induction of DC Maturation by NK Cells. 
 
Maturation
was evaluated on DC cultured with IL-2–activated or un-
treated NK cells in the same well or across a porous mem-
brane. Strong CD86 expression was induced on DC cul-
tured in contact with IL-2–activated NK cells (Fig. 4 A),
whereas a much lower expression was induced on DC ex-
posed across a porous membrane to IL-2–activated NK
cells, either mixed with DC or not (Fig. 4 C).
We evaluated whether IFN-
 
 
 
 and TNF mediate the DC
maturation effect of NK cells. IL-2–activated NK cells pro-
duced IFN-
 
 
 
 (from undetectable to 200 U/ml in seven dif-
ferent experiments), whereas TNF was always below the
limit of detection. Immature DC spontaneously secreted
TNF (from undetectable to 1.1 ng/ml). In cocultures,
TNF was detected by intracytoplamic immunofluorescence
in DC, but not in resting or in IL-2–activated NK, and its
expression was increased in comparison to DC cultured
alone (unpublished data). CD86 expression in DC treated
for 18 h with human recombinant IFN-
 
 
 
 (1,000 or 100
Figure 2. Cytokine production and CD86 expression on DC in mixed
culture of NK cells and DC. Fresh NK cells and DC were cultured sepa-
rately or together in the absence of any stimulus (medium), or in the pres-
ence of IFN- , killed M. tuberculosis (M. t.), or LPS. (A) IL-12 p70, p40,
and IFN-  were measured in culture supernatants. Two or one asterisks
indicate P   0.005 or P   0.05, respectively, by Student’s t test, using
two-tailed distribution of paired samples, comparing cytokine production
by cells cultured separately or together. (B) CD86 expression was deter-
mined on DC. 
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U/ml) or TNF (20 ng/ml) was negligible, whereas it was in-
duced by the combination of the two cytokines, although
at a much lower level than that induced by IL-2–activated
NK cells (unpublished data). A combination of neutralizing
anti–IFN-
 
 
 
 and anti-TNF mAb only partially decreased
CD86 expression in DC cultured with IL-2–activated NK
cells (Fig. 4 B). CD86 expression in DC exposed across a
porous membrane to IL-2–activated NK–DC cocultures,
in contrast, was completely abrogated by the mAb (Fig. 4
D). Results using neutralizing anti–IFN-
 
 
 
 and anti-TNF
mAb separately indicated a predominant role of TNF in
DC maturation (unpublished data).
 
Discussion
 
In this paper we demonstrate for the first time a bidirec-
tional cross talk between NK cells and DC resulting in acti-
vation of both cell types. In the presence of a maturation
stimulus, DC activate NK cells that in turn strongly en-
hance DC maturation. Previous reports in murine (3) and
human (4, 5) models demonstrated that DC enhance the
cytolytic activity of resting NK cells. However, the re-
quirement for direct NK–DC contact, soluble factors, and
DC maturation varies in the different studies. We show
that human DC, matured by microbial stimuli, induce in
resting NK cells the expression of the CD69 activation an-
tigen and a strong cytolytic activity against NK-resistant
target cells. This effect depends on cell to cell contact,
whereas it is independent from endogenous production of
IL-12 or IL-2.
In the mixed cultures of NK cells and DC in the pres-
ence of DC maturation stimuli, not only were NK cells ac-
Figure 3. IL-2–activated NK
cells induce DC maturation. (A
and B) DC were cultured for
18 h in medium only or in the
presence of LPS, IL-2–acti-
vated [NK(IL-2)] or untreated
[NK(medium)] NK cells. (A)
Cells were washed and DC ex-
pression of CD86, CD83,
CD80, HLA-DR, and CCR7
was analyzed by immunofluores-
cence. (B) DC, depleted of NK
cells and irradiated, were cul-
tured for 5 d with allogeneic na-
ive CD4  PBL, and 3H-TdR
uptake was determined. (C) CD86
expression was determined on
DC after an 18-h culture in
the absence of any stimulus,
or with PBL, or NK-depleted
PBL (PBL–NK), either IL-2–
activated or untreated.
Figure 4. Contact between IL-2–activated NK cells and immature DC
is required for induction of CD86 on DC. CD86 was evaluated on DC cul-
tured for 18 h in the same well (A and B) with IL-2–activated [NK(IL-2)]
or untreated [NK(medium)] NK cells, or across a porous membrane (C
and D) from IL-2–activated NK cells and DC, untreated NK cells and
DC, or IL-2–activated NK cells (C) in the absence (A and C) or in the
presence (B and D) of neutralizing anti–IFN-  plus anti-TNF mAb.
CD86 expression in DC cultured in the absence of NK cells (medium) is
indicated by dotted lines. Numbers in brackets indicate percent recovery
of DC after culture with IL-2–activated NK cells in comparison to DC
cultured alone.331 Gerosa et al.
tivated, but also a much stronger DC maturation was ob-
served than in the absence of NK cells. The presence of
NK cells increased both the expression of the costimulatory
molecule CD86 on DC and the production of IL-12. The
effect of NK cells was particularly dramatic when relatively
inefficient maturation inducers such as IFN-  and M. tuber-
culosis or suboptimal concentrations of LPS were used. In
particular, it is of interest to note that IFN-  alone was al-
most inefficient in inducing either activation of NK cell cy-
totoxicity or DC maturation, but very potent in the mixed
cultures, suggesting a positive feedback loop that augments
both NK activation and DC maturation.
To dissect the mechanism of DC maturation mediated
by activated NK cells in the absence of other maturation
stimuli, we used IL-2–activated NK cells. IL-2, a strong ac-
tivator of NK cells even in the absence of accessory cells
such as DC, does not act directly on DC-inducing matura-
tion. IL-2–activated NK cells induced DC maturation at a
similar extent as LPS, as indicated by increased expression
of several maturation markers (CD80, CD83, CD86,
HLA-DR, and CCR7) and ability to induce an allogeneic
T lymphocyte response. Although activated T cells also in-
duce DC maturation, NK cells are the only resting cell type
within peripheral blood that can be rapidly activated by IL-2
or mature DC to mediate this function.
Direct cell to cell contact between IL-2–activated NK
cells and DC is necessary for a strong CD86 expression in
DC. This effect does not require IFN-  and TNF produc-
tion, because a combination of neutralizing antibodies able
to inhibit much higher concentrations of the two cytokines
than those produced in the mixed cultures only marginally
inhibited DC maturation. However, TNF, produced by
DC, and IFN- , produced by IL-2–activated NK cells,
variably contribute to enhance induction of DC matura-
tion. High concentrations of recombinant IFN-  and TNF
synergized to induce DC maturation, but never to the ex-
tent induced by IL-2–activated NK cells or by LPS. It re-
mains to be evaluated whether other soluble factor(s) might
be required.
The ability of cytokine-activated NK cells to lyse im-
mature DC much more efficiently than the mature ones
(7, 8, and unpublished data) could suggest that the ob-
served, increased expression of maturation markers after
culture of DC with IL-2–activated NK cells were due to
the selective survival of a proportion of mature DC, al-
ready present within the population or induced by the re-
leased cytokines. However, an analysis of the high percent
recovery of the DC cocultured with the activated NK
cells, and the low number of mature DC in the population
even after exposure to the soluble factors released by the
NK–DC cultures, clearly shows that a selective lysis of im-
mature DC may only minimally contribute to the strongly
increased CD86 expression observed in DC after coculture
with IL-2–activated NK cells. Because exposure to ne-
crotic cells induces DC maturation (9), exposure to the
DC killed by IL-2–activated NK cells might contribute to
the maturation of bystander DC. Indeed expression of
CD86 antigen was induced on immature DC cultured in
the presence of up to 70% DC killed by repeated freezing
and thawing. However, that concentration of necrotic
cells was much higher than that observed in the mixed
cultures, and the level of CD86 induced in these condi-
tions was much lower than that induced by IL-2–activated
NK cells, suggesting only a secondary role, if any, for ne-
crotic DC uptake in the mechanism of NK cell–induced
DC maturation.
The interaction of immature DC with IL-2–activated
NK cells results in either maturation or cell death. The
mechanisms that determine the choice between death and
maturation when DC are exposed to activated NK cells re-
main to be evaluated. At higher NK–DC ratios than those
used here to study DC maturation, predominant DC death
rather than maturation was indeed observed. Receptors
mediating the NK cell–mediated lysis of DC (10, 11) might
also be responsible for induction of DC maturation. TNF
family ligands are involved in NK cell–mediated target lysis
(12, 13) and in the maturation of DC induced by activated
T cells (14–17). The ability of the neutralizing anti-TNF
mAb to partially prevent DC maturation might be partly
due to inhibition of membrane TNF, reportedly expressed
in NK cells (13, 18) in addition to the neutralization of sol-
uble TNF, released from DC. Expression of CD40 on DC
has been reported to contribute, at least in part, to lysis of
DC by cytokine-activated NK cells (7). However, the
presence of a neutralizing anti-CD40 mAb during cocul-
tures of IL-2–activated NK cells with DC, affected neither
CD86 expression nor DC recovery (unpublished data).
This result, together with the absence of CD40 ligand on
IL-2–activated NK cells (unpublished data), suggests that
other receptors may play a role in DC activation. TNF-
related activation-induced cytokine was expressed at similar
levels on both resting and activated NK cells (unpublished
data), suggesting that it does not play a determinant role in
DC maturation induced by IL-2–activated NK cells.
CD134, which mediates interactions between T lympho-
cytes and mature OX40L-expressing DC (17), increases in
NK cells after activation with IL-2 (unpublished data), sug-
gesting that it may be a candidate in mediating the interac-
tion between NK cells and DC.
The efficient cross talk between NK cells and DC is
analogous to that between activated T lymphocytes and
DC, and allows the reciprocal transfer of an activation state
between NK cells and DC. It would be expected that the
interaction between NK cells and DC is regulated in order
to prevent unnecessary activation of self-reactive or by-
stander cells. Indeed, minimal cooperation was detected
between resting NK cells and immature DC, whereas the
potent activating interaction between resting NK cells and
mature DC, and the reciprocal one between activated NK
cells and immature DC, may be functionally relevant in
different stages of the immune response. After the encoun-
ter with a pathogen, DC mature and induce activation of
resting NK cells. A different type of precursor DC, the
plasmacytoid DC, upon virus infection produces IFN- 
(19, 20) that in the presence of DC enhances the activation
of NK cells. NK cells are not only effector cells of innate332 Reciprocal Activation between Natural Killer Cells and Dendritic Cells
resistance, but also regulatory cells in both innate resistance
and adaptive immunity. They have been shown in both
humans and mice to be required for resistance to leishma-
niasis, for the induction of a Th-1 response by IL-12, and
to regulate B cell responses (21). Whereas the innate effec-
tor functions of NK cells are dependent on their cytolytic
activity, their regulatory functions have been ascribed
principally to their ability to produce cytokines early after
infection, particularly IFN- , thus favoring activation of
phagocytic cells, IL-12 production from APC, and devel-
opment of Th-1 cells that produce pro-inflammatory cyto-
kines. We now show that NK cells activated either by IL-2
or by DC exposed to microbial products or IFN- , di-
rectly induce DC maturation and strikingly enhance the
effect of microbial maturation stimuli. Thus, early during
an infection, before antigen-specific T cells are expanded,
NK cells may become activated and amplify the matura-
tion of DC induced by microbial products or by virus-
induced IFN, facilitating the activation and expansion of an-
tigen-specific naive T cells. The activated NK cells
could also lyse tumor cells and virus-, bacteria-, or para-
site-infected cells and provide immature DC with anti-
genic cellular material to be internalized and presented to
T cells upon maturation. At later stages of the response, af-
ter IL-2 release by antigen-specific Th-1 cells, IL-2–acti-
vated NK cells directly inducing the maturation of DC
might play a powerful role in enhancing the specific
immune response. Conversely, an excessive immune re-
sponse might be limited by the mechanisms that regulate
the choice between maturation and lysis of DC. Activated
NK cells when present in sufficient number may induce
death rather than activation, particularly in immature DC.
Therefore, depending on the stage and on the intensity of
the immune response, the cross talk between NK cells and
DC may result in either the initiation/amplification or the
shutting off of antigen presentation.
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